Determination of Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy Subjects
N/A
18 Years
75 Years
18 Years
75 Years
Not Enrolling
Both
Liver Cirrhosis
Both
Liver Cirrhosis
Trial Information
Determination of Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy Subjects
Inclusion Criteria:
- liver cirrhosis
Exclusion Criteria:
- hepatic encephalopathy
- pregnancy
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Lumped constant for recalculation of PET/CT data for FDGalactose to data for natural galactose
Outcome Time Frame:
May 2011
Safety Issue:
No
Principal Investigator
John Westensee, Mr
Investigator Role:
Study Director
Investigator Affiliation:
Research Support Office, Aarhus University Hospital
Authority:
Denmark: Ethics Committee
Study ID:
gal-FDGal
NCT ID:
NCT01002261
Start Date:
October 2009
Completion Date:
May 2011
Related Keywords:
- Liver Cirrhosis
- Galactose
- PET/CT
- Liver physiology
- Liver pathophysiology
- Liver Cirrhosis
- Fibrosis
- Liver Diseases
Name | Location |
|---|
